2-[2-(Trifluoromethyl)-5-[3-[3-[4-(trifluoromethyl)phenyl]prop-2-enoxy]phenoxy]phenyl]acetic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[2-(Trifluoromethyl)-5-[3-[3-[4-(trifluoromethyl)phenyl]prop-2-enoxy]phenoxy]phenyl]acetic acid
• 英文别名: 2-[2-(trifluoromethyl)-5-[3-[3-[4-(trifluoromethyl)phenyl]prop-2-enoxy]phenoxy]phenyl]acetic acid
• 化学式: C₂₅H₁₈F₆O₄
• 分子量: 496.4
• InChiKey: QHGLBTUINHEHSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  10

文献信息

• Diphenyl ether compound, process for producing the same, and use
  申请人：Kusuda Shinya

  公开号：US20100267778A1

  公开（公告）日：2010-10-21

  The present invention relates to a compound represented by formula (I): wherein ring A, ring B and ring D each independently represents a cyclic group which may have a substituent(s); W is a spacer having 1 to 8 atom(s) in its main chain; X is a spacer having 1 to 2 atom(s) in its main chain; Y is a binding bond or a spacer having 1 to 8 atom(s) in its main chain; and Z is an acidic group, or a salt thereof, a solvate thereof or a prodrug thereof. The compound represented by formula (I) has a PPAR δ agonistic action and is useful as a preventive and/or treating agent for diseases where sugar and lipid metabolisms are abnormal (diabetes, hyperlipemia, arteriosclerosis, cardiovascular diseases, obesity and metabolic syndrome or the like), hypertension, circulatory diseases and skin inflammation diseases.

  本发明涉及一种由式(I)表示的化合物：其中环A、环B和环D各自独立地表示可能具有取代基的环状基团；W是具有1至8个原子的主链的间隔物；X是具有1至2个原子的主链的间隔物；Y是结合键或具有1至8个原子的主链的间隔物；Z是酸性基团或其盐、溶剂化物或前药。由式(I)表示的化合物具有PPARδ激动作用，可用作糖和脂质代谢异常疾病（糖尿病、高脂血症、动脉硬化、心血管疾病、肥胖症和代谢综合征等）、高血压、循环系统疾病和皮肤炎症疾病的预防和/或治疗剂。